220 related articles for article (PubMed ID: 29305416)
1. Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease.
Lefebvre T; Reihani N; Daher R; de Villemeur TB; Belmatoug N; Rose C; Colin-Aronovicz Y; Puy H; Le Van Kim C; Franco M; Karim Z
Haematologica; 2018 Apr; 103(4):587-596. PubMed ID: 29305416
[TBL] [Abstract][Full Text] [Related]
2. Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications.
Regenboog M; van Kuilenburg AB; Verheij J; Swinkels DW; Hollak CE
Blood Rev; 2016 Nov; 30(6):431-437. PubMed ID: 27265538
[TBL] [Abstract][Full Text] [Related]
3. Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1.
Lorenz F; Pawłowicz E; Klimkowska M; Beshara S; Bulanda Brustad A; Skotnicki AB; Wahlin A; Machaczka M
Blood Cells Mol Dis; 2018 Feb; 68():35-42. PubMed ID: 27816428
[TBL] [Abstract][Full Text] [Related]
4. Iron homeostasis and infIammatory biomarker analysis in patients with type 1 Gaucher disease.
Medrano-Engay B; Irun P; Gervas-Arruga J; Andrade-Campos M; Andreu V; Alfonso P; Pocovi M; Giraldo P
Blood Cells Mol Dis; 2014 Dec; 53(4):171-5. PubMed ID: 25153906
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
6. Ferroportin-Hepcidin Axis in Prepubertal Obese Children with Sufficient Daily Iron Intake.
Gajewska J; Ambroszkiewicz J; Klemarczyk W; Głąb-Jabłońska E; Weker H; Chełchowska M
Int J Environ Res Public Health; 2018 Oct; 15(10):. PubMed ID: 30275363
[TBL] [Abstract][Full Text] [Related]
7. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
[TBL] [Abstract][Full Text] [Related]
8. Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin.
Eleftheriadis T; Pissas G; Remoundou M; Filippidis G; Antoniadi G; Oustampasidou N; Liakopoulos V; Stefanidis I
Int Urol Nephrol; 2014 Jan; 46(1):161-7. PubMed ID: 23860963
[TBL] [Abstract][Full Text] [Related]
9. Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment.
Mekinian A; Stirnemann J; Belmatoug N; Heraoui D; Fantin B; Fain O; Charpentier A; Rose C
Blood Cells Mol Dis; 2012 Jun; 49(1):53-7. PubMed ID: 22560483
[TBL] [Abstract][Full Text] [Related]
10. [Siwu decoction improves iron deficiency anemia in infant rats and regulates iron metabolism].
He R; Wang HJ; Zhou Y; Li JJ; Xu XY
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):944-950. PubMed ID: 28994539
[TBL] [Abstract][Full Text] [Related]
11. Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome.
Rauber MR; Pilger DA; Cecconello DK; Falcetta FS; Marcondes NA; Faulhaber GAM
An Acad Bras Cienc; 2019 May; 91(2):e20180286. PubMed ID: 31090790
[TBL] [Abstract][Full Text] [Related]
12. Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes.
Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Green K; Makdissi A; Chaudhuri A; Dandona P
Clin Endocrinol (Oxf); 2016 Nov; 85(5):772-780. PubMed ID: 27292585
[TBL] [Abstract][Full Text] [Related]
13. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.
van Dussen L; Hendriks EJ; Groener JE; Boot RG; Hollak CE; Aerts JM
J Inherit Metab Dis; 2014 Nov; 37(6):991-1001. PubMed ID: 24831585
[TBL] [Abstract][Full Text] [Related]
14. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice.
Tajima S; Ikeda Y; Enomoto H; Imao M; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
Eur J Nutr; 2015 Aug; 54(5):709-19. PubMed ID: 25096756
[TBL] [Abstract][Full Text] [Related]
16. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
[TBL] [Abstract][Full Text] [Related]
17. Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.
Nekhai S; Xu M; Foster A; Kasvosve I; Diaz S; Machado RF; Castro OL; Kato GJ; Taylor JG; Gordeuk VR
Haematologica; 2013 Mar; 98(3):455-63. PubMed ID: 23065513
[TBL] [Abstract][Full Text] [Related]
18. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
Ganz T; Nemeth E
Semin Nephrol; 2016 Mar; 36(2):87-93. PubMed ID: 27236128
[TBL] [Abstract][Full Text] [Related]
19. Association between Consumption of Cow's Milk and Iron Deficiency Anemia in Children: Are There Roles for Hepcidin-25/Ferroportin? A Case-Control Study.
Vehapoglu A; Ozgurhan G; Ustabas Kahraman F; Cakın ZE; Sumbul B
Pediatr Hematol Oncol; 2020 Nov; 37(8):676-686. PubMed ID: 32705943
[TBL] [Abstract][Full Text] [Related]
20. Iron metabolism in hepcidin1 knockout mice in response to phenylhydrazine-induced hemolysis.
Masaratana P; Latunde-Dada GO; Patel N; Simpson RJ; Vaulont S; McKie AT
Blood Cells Mol Dis; 2012 Aug; 49(2):85-91. PubMed ID: 22609087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
